Darrick A Carter

US Patent:

6509448, Jan 21, 2003

Filed:

Dec 13, 2000

Appl. No.:

09/736457

Inventors:

Tongtong Wang - Medina WA
Chaitanya S. Bangur - Seattle WA
Michael J. Lodes - Seattle WA
Gary R. Fanger - Mill Creek WA
Thomas S. Vedvick - Federal Way WA
Darrick Carter - Seattle WA
Marc W. Retter - Carnation WA
Jane Mannion - Edmonds WA
Liqun Fan - Bellevue WA
Aijun Wang - Issaquah WA

Assignee:

Corixa Corporation - Seattle WA

International Classification:

C07K 1618

US Classification:

5303879

Abstract:

Compositions and methods for the therapy and diagnosis of cancer, particularly lung cancer, are disclosed. Illustrative compositions comprise one or more lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung cancer.

US Patent:

6512094, Jan 28, 2003

Filed:

Jun 13, 2000

Appl. No.:

09/593793

Inventors:

Jiangchun Xu - Bellevue WA
Davin C. Dillon - Issaquah WA
Jennifer L. Mitcham - Redmond WA
Susan L. Harlocker - Seattle WA
Yuqiu Jiang - Kent WA
Michael D. Kalos - Seattle WA
Gary R. Fanger - Mill Creek WA
Marc W. Retter - Carnation WA
John A. Stolk - Bothell WA
Craig H. Day - Seattle WA
Thomas S. Vedvick - Federal Way WA
Darrick Carter - Seattle WA
Samuel X. Li - Redmond WA
Aijun Wang - Issaquah WA
Yasir A. W. Skeiky - Bellevue WA
William T. Hepler - Seattle WA
Robert A. Henderson - Edmonds WA

Assignee:

Corixa Corporation - Seattle WA

International Classification:

C07K 100

US Classification:

530350, 435 911, 435 912, 435 5, 435 6, 42419711, 4241841, 4241851, 536 231, 536 237, 530352, 530380

Abstract:

Compositions and methods for the therapy and diagnosis of cancer, such as prostate cancer, are disclosed. Compositions may comprise one or more prostate-specific proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a prostate-specific protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as prostate cancer. Diagnostic methods based on detecting a prostate-specific protein, or mRNA encoding such a protein, in a sample are also provided.

US Patent:

6620922, Sep 16, 2003

Filed:

Aug 9, 2000

Appl. No.:

09/636215

Inventors:

Jiangchun Xu - Bellevue WA
Davin C. Dillon - Issaquah WA
Jennifer L. Mitcham - Redmond WA
Susan L. Harlocker - Seattle WA
Yuqiu Jiang - Kent WA
Michael D. Kalos - Seattle WA
Gary R. Fanger - Mill Creek WA
Marc W. Retter - Carnation WA
John A. Stolk - Bothell WA
Craig H. Day - Seattle WA
Thomas S. Vedvick - Federal Way WA
Darrick Carter - Seattle WA
Samuel X. Li - Redmond WA
Aijun Wang - Issaquah WA
Yasir A. W. Skeiky - Bellevue WA
William T. Hepler - Seattle WA
Robert A. Henderson - Edmonds WA

Assignee:

Corixa Corporation - Seattle WA

International Classification:

C07H 2104

US Classification:

536 231, 536 234, 536 241, 536 2431, 536 2433, 536 235, 435 6, 435 911

Abstract:

Compositions and methods for the therapy and diagnosis of cancer, such as prostate cancer, are disclosed. Compositions may comprise one or more prostate-specific proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a prostate-specific protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as prostate cancer. Diagnostic methods based on detecting a prostate-specific protein, or mRNA encoding such a protein, in a sample are also provided.

US Patent:

6630305, Oct 7, 2003

Filed:

Oct 10, 2000

Appl. No.:

09/685166

Inventors:

Jiangchun Xu - Bellevue WA
Davin C. Dillon - Issaquah WA
Jennifer L. Mitcham - Redmond WA
Susan L. Harlocker - Seattle WA
Yuqiu Jiang - Kent WA
Michael D. Kalos - Seattle WA
Gary R. Fanger - Mill Creek WA
Marc W. Retter - Carnation WA
John A. Stolk - Bothell WA
Craig H. Day - Seattle WA
Thomas S. Vedvick - Federal Way WA
Darrick Carter - Seattle WA
Samuel X. Li - Redmond WA
Aijun Wang - Issaquah WA
Yasir A. W. Skeiky - Bellevue WA
William T. Hepler - Seattle WA
Robert A. Henderson - Edmonds WA

Assignee:

Corixa Corporation - Seattle WA

International Classification:

C12Q 168

US Classification:

435 6, 4353201, 4352523, 435325, 536 231, 536 241

Abstract:

Compositions and methods for the therapy and diagnosis of cancer, particularly prostate cancer, are disclosed. Illustrative compositions comprise one or more prostate-specific polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly prostate cancer.

US Patent:

6630574, Oct 7, 2003

Filed:

Jul 11, 2000

Appl. No.:

09/614124

Inventors:

Tongtong Wang - Medina WA
Chaitanya S. Bangur - Seattle WA
Michael J. Lodes - Seattle WA
Gary R. Fanger - Mill Creek WA
Thomas S. Vedvick - Federal Way WA
Darrick Carter - Seattle WA
Marc W. Retter - Carnation WA
Jane Mannion - Edmonds WA
Liqun Fan - Bellevue WA

Assignee:

Corixa Corporation - Seattle WA

International Classification:

A61K 3816

US Classification:

530350, 530300, 4241841

Abstract:

Compositions comprising isolated cancer-associated L552S polypeptides are disclosed. Such compositions can comprise, for example, portions of said cancer-associated L552S polypeptides and/or the corresponding polynucleotides encoding such portions. Illustrative uses of the compositions, for example in cancer diagnostic methods, are also provided.

US Patent:

6667154, Dec 23, 2003

Filed:

Sep 26, 2000

Appl. No.:

09/671325

Inventors:

Tongtong Wang - Medina WA
Chaitanya S. Bangur - Seattle WA
Michael J. Lodes - Seattle WA
Gary R. Fanger - Mill Creek WA
Thomas S. Vedvick - Federal Way WA
Darrick Carter - Seattle WA
Marc W. Retter - Carnation WA
Jane Mannion - Edmonds WA
Liqun Fan - Bellevue WA

Assignee:

Corixa Corporation - Seattle WA

International Classification:

C12Q 168

US Classification:

435 6, 435 911, 435 912, 536 231, 536 2432, 536 2433

Abstract:

Compositions and methods for the therapy and diagnosis of cancer, such as lung cancer, are disclosed. Compositions may comprise one or more lung tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a lung tumor protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as lung cancer. Diagnostic methods based on detecting a lung tumor protein, or mRNA encoding such a protein, in a sample are also provided.

US Patent:

6699664, Mar 2, 2004

Filed:

Sep 20, 2000

Appl. No.:

09/667857

Inventors:

Jennifer L. Mitcham - Redmond WA
Gordon E. King - Seattle WA
Paul A. Algate - Issaquah WA
Steven P. Fling - Bainbridge Island WA
Marc W. Retter - Carnation WA
Gary R. Fanger - Mill Creek WA
Steven G. Reed - Bellevue WA
Thomas S. Vedvick - Federal Way WA
Darrick Carter - Seattle WA

Assignee:

Corixa Corporation - Seattle WA

International Classification:

C12Q 168

US Classification:

435 6, 4352523, 4353201, 435325, 536 231, 536 241

Abstract:

Compositions and methods for the therapy and diagnosis of cancer, such as ovarian cancer, are disclosed. Compositions may comprise one or more ovarian carcinoma proteins, immunogenic portions thereof, polynucleotides that encode such portions or antibodies or immune system cells specific for such proteins. Such compositions may be used, for example, for the prevention and treatment of diseases such as ovarian cancer. Methods are further provided for identifying tumor antigens that are secreted from ovarian carcinomas and/or other tumors. Polypeptides and polynucleotides as provided herein may further be used for the diagnosis and monitoring of ovarian cancer.

US Patent:

6746846, Jun 8, 2004

Filed:

Sep 8, 2000

Appl. No.:

09/658824

Inventors:

Tongtong Wang - Medina WA
Chaitanya S. Bangur - Seattle WA
Michael J. Lodes - Seattle WA
Gary R. Fanger - Mill Creek WA
Thomas S. Vedvick - Federal Way WA
Darrick Carter - Seattle WA
Marc W. Retter - Carnation WA
Jane Mannion - Edmonds WA
Liqun Fan - Bellevue WA

Assignee:

Corixa Corporation - Seattle WA

International Classification:

G01N 33574

US Classification:

435 71, 435 721, 435 723, 530300, 530350

Abstract:

Compositions and methods for the therapy and diagnosis of cancer, such as lung cancer, are disclosed. Compositions may comprise one or more lung tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a lung tumor protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as lung cancer. Diagnostic methods based on detecting a lung tumor protein, or mRNA encoding such a protein, in a sample are also provide.